Drug-related infant deaths surge in the U.S., study finds
A recent study from the Journal of Perinatal Medicine reveals a significant rise in drug-related infant deaths in the U.S. between 2018 and 2022, highlighting
A recent study from the Journal of Perinatal Medicine reveals a significant rise in drug-related infant deaths in the U.S. between 2018 and 2022, highlighting
A recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.
Republican lawmakers are sharply criticizing the Food and Drug Administration’s relationship with a nonprofit group seeking to create a network of laboratories to test artificial
Extreme heat is coming this week in many parts of the United States. The Midwest and Northeast in particular will see weather that puts them
Michael Casamassa VP of Sales for Payor Solutions, Henry Schein Medical The challenge of staff shortages in healthcare continues to remain persistent in the United
What You Should Know: – Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Boston Scientific has agreed to
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medtronic’s president of global regions,
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Advamed said it supports the
Table of Contents Oregon’s rule limiting the non-resident ownership of licensed psilocybin businesses sunsets on December 31, 2024. That’s a little over six months away.